Ozempic is designed primarily for diabetes treatment, and weight loss is considered a secondary but clinically valuable effect
The favorable results from the placebo-controlled FLOW trial, conducted with semaglutide 1.0 mg in patients with T2D and chronic kidney disesase (CKD), are about to be disclosed, while ongoing dedicated trials will further explore the effects of OW semaglutide 2.4 mg (NCT04889183) and tirzepatide (NCT05536804) on kidney function parameters in obese/overweight individuals at high risk of CKD progression regardless of T2D
Lightweight Daily Facial Serum Fast-absorbing, non-greasy formula spreads smoothly across the skin and layers comfortably under moisturizers, sunscreen, and makeup
because B vitamins are essential for a wide range of functions in the body
I spent five days in hospital and, of course, they gave me a lot of painkillers